Rivaroxaban: Drug review

Rivaroxaban: Drug review

Cancer-associated thrombosis is a challenging problem when treating patients with cancer. It is recurrent and difficult to treat because of the increased risk of bleeding. Low-molecular-weight heparin is the standard of care for treating cancer-associated venous thromboembolism/pulmonary embolism (V...

Full description

Bibliographic Details
Main Authors: Abhishek Kumar Singh, Vanita Noronha, Anuj Gupta, Deepak Singh, Parul Singh, Amrita Singh, Arpita Singh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Cancer Research, Statistics, and Treatment
Subjects:
anticoagulant therapy
cancer-associated thrombosis
direct oral anticoagulant
pulmonary embolism
venous thromboembolism
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=2;spage=264;epage=269;aulast=Singh

Internet

http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=2;spage=264;epage=269;aulast=Singh

Similar Items